The Longaevus team took part in BIO-Europe

07 November 2023
Ivan Morgunov (founder of Longaevus Technologies), Sherif Idriss (CEO of Elastin Therapeutics (Longaevus’ spin-off)), Francesca Lugarini (CEO of SeneXell Project (Longaevus’ spin-off)) and Alexander Fedintsev (a specialist in extracellular matrix biology and advisor of Longaevus Biotech) at Bio-Europe 2023 in Munich, Germany.

Ivan Morgunov (founder of Longaevus Technologies), Sherif Idriss (CEO of Elastin Therapeutics (Longaevus’ spin-off)), Francesca Lugarini (CEO of SeneXell Project (Longaevus’ spin-off)) and Alexander Fedintsev (a specialist in extracellular matrix biology and advisor of Longaevus Biotech) at Bio-Europe 2023 in Munich, Germany.

Longaevus Team has participated in the 9th annual BIO-Europe event. BIO-Europe is the largest partnering event throughout Europe for the international biotech and pharmaceutical scene, which took place on November 6–8, 2023 in Munich, Germany.